Literature DB >> 20346061

T cell-mediated rejection of kidney transplants: a personal viewpoint.

P F Halloran1.   

Abstract

In kidney allografts, T cell mediated rejection (TCMR) is characterized by infiltration of the interstitium by T cells and macrophages, intense IFNG and TGFB effects, and epithelial deterioration. Recent experimental and clinical studies provide the basis for a provisional model for TCMR. The model proposes that the major unit of cognate recognition in TCMR is effector T cells engaging donor antigen on macrophages. This event creates the inflammatory compartment that recruits effector and effector memory CD4 and CD8 T cells, both cognate and noncognate, and macrophage precursors. Cognate T cells cross the donor microcirculation to enter the interstitium but spare the microcirculation. Local inflammation triggers dedifferentiation of the adjacent epithelium (e.g. loss of transporters and expression of embryonic genes) rather than cell death, via mechanisms that do not require known T-cell cytotoxic mechanisms or direct contact of T cells with the epithelium. Local epithelial changes trigger a response of the entire nephron and a second wave of dedifferentiation. The dedifferentiated epithelium is unable to exclude T cells, which enter to produce tubulitis lesions. Thus TCMR is a cognate recognition-based process that creates local inflammation and epithelial dedifferentiation, stereotyped nephron responses, and tubulitis, and if untreated causes irreversible nephron loss.

Entities:  

Mesh:

Year:  2010        PMID: 20346061     DOI: 10.1111/j.1600-6143.2010.03053.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  27 in total

1.  Soothing touch of CD31 protects endothelium during cellular immune responses.

Authors:  Olivier Thaunat
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-19       Impact factor: 11.205

2.  Human renal tubular epithelial cells suppress alloreactive T cell proliferation.

Authors:  M W H J Demmers; S S Korevaar; M Roemeling-van Rhijn; T P P van den Bosch; M J Hoogduijn; M G H Betjes; W Weimar; C C Baan; A T Rowshani
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

Review 3.  Alloimmune T cells in transplantation.

Authors:  Susan DeWolf; Megan Sykes
Journal:  J Clin Invest       Date:  2017-06-19       Impact factor: 14.808

4.  Systems biology approach to transplant tolerance: proof of concept experiments using RNA interference (RNAi) to knock down hub genes in Jurkat and HeLa cells in vitro.

Authors:  Wint Wah Lwin; Ken Park; Matthew Wauson; Qin Gao; Patricia W Finn; David Perkins; Ajai Khanna
Journal:  J Surg Res       Date:  2011-12-22       Impact factor: 2.192

Review 5.  [Chronic rejection: Differences and similarities in various solid organ transplants].

Authors:  H Suhling; J Gottlieb; C Bara; R Taubert; E Jäckel; M Schiffer; J H Bräsen
Journal:  Internist (Berl)       Date:  2016-01       Impact factor: 0.743

6.  Genome-wide non-HLA donor-recipient genetic differences influence renal allograft survival via early allograft fibrosis.

Authors:  Zhongyang Zhang; Madhav C Menon; Weijia Zhang; Eli Stahl; Bao-Li Loza; Ivy A Rosales; Zhengzi Yi; Khadija Banu; Felipe Garzon; Zeguo Sun; Chengguo Wei; Weiqing Huang; Qisheng Lin; Ajay Israni; Brendan J Keating; Robert B Colvin; Ke Hao; Barbara Murphy
Journal:  Kidney Int       Date:  2020-05-23       Impact factor: 10.612

7.  Bβ(15-42) attenuates the effect of ischemia-reperfusion injury in renal transplantation.

Authors:  Inga Sörensen; Song Rong; Nathan Susnik; Faikah Gueler; Nelli Shushakova; Melanie Albrecht; Anna-Maria Dittrich; Sibylle von Vietinghoff; Jan Ulrich Becker; Anette Melk; Andrea Bohlmann; Sonja Reingruber; Peter Petzelbauer; Hermann Haller; Roland Schmitt
Journal:  J Am Soc Nephrol       Date:  2011-08-12       Impact factor: 10.121

8.  Derivation and validation of a cytokine-based assay to screen for acute rejection in renal transplant recipients.

Authors:  Sacha A De Serres; Bechara G Mfarrej; Monica Grafals; Leonardo V Riella; Ciara N Magee; Melissa Y Yeung; Christine Dyer; Usaila Ahmad; Anil Chandraker; Nader Najafian
Journal:  Clin J Am Soc Nephrol       Date:  2012-04-12       Impact factor: 8.237

Review 9.  Neutrophil gelatinase-associated lipocalin: ready for routine clinical use? An international perspective.

Authors:  Claudio Ronco; Matthieu Legrand; Stuart L Goldstein; Mina Hur; Nam Tran; Eric C Howell; Vincenzo Cantaluppi; Dinna N Cruz; Kevin Damman; Sean M Bagshaw; Salvatore Di Somma; Andrew Lewington
Journal:  Blood Purif       Date:  2014-07-03       Impact factor: 2.614

Review 10.  The Use of Genomics and Pathway Analysis in Our Understanding and Prediction of Clinical Renal Transplant Injury.

Authors:  Madhav C Menon; Karen L Keung; Barbara Murphy; Philip J OʼConnell
Journal:  Transplantation       Date:  2016-07       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.